These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2529158)

  • 1. Comparison of high- and low-diabetes-incidence NOD mouse strains.
    Baxter AG; Adams MA; Mandel TE
    Diabetes; 1989 Oct; 38(10):1296-300. PubMed ID: 2529158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective activation of T suppressor cell function in nonobese diabetic mice. Potential relation to cytokine deficiencies.
    Serreze DV; Leiter EH
    J Immunol; 1988 Jun; 140(11):3801-7. PubMed ID: 2897395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunostimulation circumvents diabetes in NOD/Lt mice.
    Serreze DV; Hamaguchi K; Leiter EH
    J Autoimmun; 1989 Dec; 2(6):759-76. PubMed ID: 2533502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclophosphamide-induced diabetes in NOD/WEHI mice. Evidence for suppression in spontaneous autoimmune diabetes mellitus.
    Charlton B; Bacelj A; Slattery RM; Mandel TE
    Diabetes; 1989 Apr; 38(4):441-7. PubMed ID: 2522407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous TNF production differs between high and low diabetes incidence non-obese diabetic (NOD) mice.
    Chosich N; Rockett E; Harrison LC
    Autoimmunity; 1994; 18(3):163-8. PubMed ID: 7858101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of diabetogenesis in NOD/Lt mice. Development and analysis of congenic stocks.
    Prochazka M; Serreze DV; Worthen SM; Leiter EH
    Diabetes; 1989 Nov; 38(11):1446-55. PubMed ID: 2576007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice.
    Wicker LS; Miller BJ; Mullen Y
    Diabetes; 1986 Aug; 35(8):855-60. PubMed ID: 3525284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
    Shultz LD; Schweitzer PA; Christianson SW; Gott B; Schweitzer IB; Tennent B; McKenna S; Mobraaten L; Rajan TV; Greiner DL
    J Immunol; 1995 Jan; 154(1):180-91. PubMed ID: 7995938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
    Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
    J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal injections of cyclosporin enhance autoimmune diabetes in non-obese diabetic mice.
    Saï P; Senecat O; Martignat L; Gouin E
    Clin Exp Immunol; 1994 Jul; 97(1):138-45. PubMed ID: 8033411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal allogeneic bone marrow transplantation between NOD mice and diabetes-nonsusceptible mice associated with transfer and prevention of autoimmune diabetes.
    LaFace DM; Peck AB
    Diabetes; 1989 Jul; 38(7):894-901. PubMed ID: 2661286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice.
    Prochazka M; Serreze DV; Frankel WN; Leiter EH
    Diabetes; 1992 Jan; 41(1):98-106. PubMed ID: 1727742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice.
    Li H; Kaufman CL; Boggs SS; Johnson PC; Patrene KD; Ildstad ST
    J Immunol; 1996 Jan; 156(1):380-8. PubMed ID: 8598488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of insulitis and diabetes onset by treatment with complete Freund's adjuvant in NOD mice.
    McInerney MF; Pek SB; Thomas DW
    Diabetes; 1991 Jun; 40(6):715-25. PubMed ID: 2040388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of autoimmune diabetes with lymphotoxin in NOD mice.
    Seino H; Takahashi K; Satoh J; Zhu XP; Sagara M; Masuda T; Nobunaga T; Funahashi I; Kajikawa T; Toyota T
    Diabetes; 1993 Mar; 42(3):398-404. PubMed ID: 8432410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes.
    Gerling IC; Friedman H; Greiner DL; Shultz LD; Leiter EH
    Diabetes; 1994 Mar; 43(3):433-40. PubMed ID: 8314017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.
    Hammond KJ; Poulton LD; Palmisano LJ; Silveira PA; Godfrey DI; Baxter AG
    J Exp Med; 1998 Apr; 187(7):1047-56. PubMed ID: 9529321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice.
    Yasunami R; Bach JF
    Eur J Immunol; 1988 Mar; 18(3):481-4. PubMed ID: 2965652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic dendritic cells from the non-obese diabetic mouse induce a prolonged proliferation of syngeneic T cells. A role for an impaired apoptosis of NOD T cells?
    Radosevic K; Casteels KM; Mathieu C; Van Ewijk W; Drexhage HA; Leenen PJ
    J Autoimmun; 1999 Dec; 13(4):373-82. PubMed ID: 10585753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.